February 27, 2017 by Greg Jacobson and Chain Drug Review
ACA, ACA exchanges, Aetna, Affordable Care Act, Health and Human Services, health insurance exchanges, Humana, Mark Bertolini, Obamacare, Tom Price, Trump administration
2017, Issue 02-27-2017, Issues, News
WASHINGTON — Humana Inc.’s decision to pull out of the health insurance exchanges created by the Affordable Care Act threatens to cripple Obamacare before Republican lawmakers bent on its repeal can cobble together a replacement. The Humana decision came one day before the Trump administration issued a proposed rule that attempts to offer insurers more
February 21, 2017 by Greg Jacobson and Chain Drug Review
ACA, Aetna, Affordable Care Act, health insurance exchanges, Humana, Mark Bertolini, Obamacare, Tom Price
Featured Articles, Leading Headlines, Pharmacy, Retail News
WASHINGTON — Humana Inc.’s decision to pull out of the health insurance exchanges created by the Affordable Care Act threatens to cripple Obamacare before Republican lawmakers bent on its repeal can cobble together a replacement. The Humana decision came one day before the Trump White House issued a proposed rule that attempts to offer insurers
February 15, 2017 by Chain Drug Review
Aetna, Affordable Care Act, Anthem, Anthem-Cigna merger, Bruce Broussard, Cigna, health insurance sector, health insurer mega-mergers, Humana
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
NEW YORK — More turbulence has hit the health insurance sector with the apparent breakup of the Anthem-Cigna merger and Humana Inc.’s plan to pull out of the exchange market. Anthem Inc. on Wednesday said it has filed a lawsuit in the Delaware Court of Chancery against Cigna Corp., which yesterday afternoon announced its aim
February 14, 2017 by Chain Drug Review
Aetna, Affordable Care Act, Anthem, Cigna, health insurance, Humana, Joseph Swedish, Mark Bertolini
Business, Leading Headlines, Pharmacy, Retail News
HARTFORD, Conn., and LOUISVILLE, Ky. — After being blocked by a federal court, Aetna Inc. and Humana Inc. have decided to terminate their $37 billion merger deal. The health insurance giants said Tuesday that, with the move, Aetna will pay Humana a $1 billion breakup fee. Aetna said it also has ended its agreement to
February 6, 2017 by Mark Baumgartner and Chain Drug Review
Aetna, Aetna-Humana merger, Affordable Care Act, Anthem-Cigna merger, Bruce Broussard, health insurers, Humana, Mark Bertolini, Medicare Advantage
2017, Issue 02-06-2017, Issues, News
WASHINGTON — A federal judge last month temporarily blocked Aetna Inc.’s proposed acquisition of Humana Inc. The move stemmed from a ruling on a lawsuit brought last year by the Justice Department to prevent the health insurers from merging on the grounds that the deal would produce higher prices for consumers and fewer services for
September 6, 2016 by Geoff Walden and Chain Drug Review
ACA enrollment, Aetna, Affordable Care Act, Drew Altman, health insurance exchanges, health insurance marketplaces, Humana, Kaiser Family Foundation, Marilyn Tavenner, Mark Bertolini, UnitedHealth Group
Issue 09-12-2016, Leading Headlines, News, Pharmacy, Retail News
WASHINGTON — The pullback of health insurance companies from the Affordable Care Act has focused a harsh light on President Obama’s signature legislative achievement. Most recently, Aetna Inc. decided to drop out of ACA health insurance exchanges in 11 states with about two-thirds of the 778 counties where it now offers coverage. It will continue
September 10, 2015 by Chain Drug Review
Aetna, Anthem, B. Douglas Hoey, Bob Goodlatte, Cigna, health insurer mega-mergers, Humana, National Community Pharmacists Association, NCPA, PBMs
CDR Blog
Congressional scrutiny of the recent health insurer mega-mergers is a welcome sight, according to B. Douglas Hoey, CEO of the National Community Pharmacists Association. This summer, health insurer M&As reached a peak with Anthem’s $48 billion purchase of Cigna and Aetna’s $34 billion acquisition of Humana. On Thursday, the House Judiciary Committee’s Subcommittee on Regulatory
August 10, 2015 by Geoff Walden and Chain Drug Review
Aetna, Affordable Care Act, Anthem, chain drug retailers, chain pharmacies, Cigna, health insurance industry, health insurer consolidation, health insurer megadeals, Humana, Joseph Swedish, Mark Bertolini, Medicaid business, Medicare Advantage plans
2015, Issue 08-10-2015, Issues, News
NEW YORK — Chain drug retailers have gotten used to dealing with fewer, and larger, drug makers, wholesalers and pharmacy benefit managers over the years. Retailers themselves have also consolidated, and now a merger wave has washed over the health insurance industry. While acquisitions in other sectors have been driven by the pursuit of economies
August 4, 2015 by Chain Drug Review
Aetna, Affordable Care Act, Anthem, chain drug stores, chain pharmacies, Cigna, health insurance industry, Humana, Medicaid business, Medicare Advantage
CDR Blog
Drug chains have gotten used to dealing with fewer, and larger, drug makers, wholesalers and PBMs over the years. Retailers have also consolidated. Now a merger wave has washed over the health insurance industry. Though acquisitions in other sectors have been driven by the pursuit of economies of scale, the health insurance consolidation is seen